Results 61 to 70 of about 30,900 (164)

DNA Synthesis in Chronic Myelogenous Leukemia Cells: Comparison of Results in Cells Containing Folate Binding Factor to Replicating Cells Without Binder [PDF]

, 1972
Maria DaCosta, Sheldon P. Rothenberg, Barton A. Kamen   +2 more
openalex   +1 more source

Modulation of Plasma 25-Hydroxyvitamin D3 Level by Imatinib Mesylate in Patients with Chronic Myelogenous Leukemia: The Role of Uptake and Efflux Transporters

Current Therapeutic Research, 2022
: Background: Vitamin D deficiency is a common side effect of imatinib mesylate (IM) therapy. Transporter polypeptides involved in the disposition of IM may be required for maintenance of adequate vitamin D concentrations.
Mervat M. Omran, MD, Samia A. Shouman, PhD, Raafat Abdelfattah, MD, Heba S. Moussa, MD, Nadia A. Thabet, Msc, Marwa S. Hamza, PhD   +5 more
doaj  

Hyperviscosity retinopathy from chronic myelogenous leukemia. [PDF]

Can J Ophthalmol, 2023
Kaplan TM, Starr MR, Dalvin LA.
europepmc   +1 more source

Sudden unilateral visual loss as an initial presentation of chronic myelogenous leukemia

Clinical Optometry, 2010
Len V Hua, Salisa K WilliamsPacific University Eye Clinic, Forest Grove, OR, USAAbstract: Leukemia is a cancer of the white blood cells. Many patients with leukemia are  unaware of their disease until routine blood work up for other conditions ...
Len V Hua, Salisa K Williams
doaj  

Chronic Myelogenous Leukemia: Cyclic Leukocytosis and Identical Twin Discordance [PDF]

, 1970
Richard A. Gatti, Amos S. Deinard, Mark E. Nesbit, William A. Robinson, Robert A. Good   +4 more
openalex   +1 more source

Sipa1 deficiency unleashes a host-immune mechanism eradicating chronic myelogenous leukemia-initiating cells

Nature Communications, 2018
Chronic myelogenous leukemia (CML)-initiating cells are resistant to kinase inhibitors. Here the authors show that deficiency of the Rap1 GTPase-activating protein Sipa1 in the tumor microenvironment releases an immune response that eradicates CML ...
Yan Xu, Satoshi Ikeda, Kentaro Sumida, Ryusuke Yamamoto, Hiroki Tanaka, Nagahiro Minato   +5 more
doaj   +1 more source

Supremacy of nanoparticles in the therapy of chronic myelogenous leukemia. [PDF]

ADMET DMPK, 2023
Janani G, Girigoswami A, Girigoswami K.
europepmc   +1 more source

Philadelphia-chromosome-positive pre-B-cell leukemia presenting as blast crisis of chronic myelogenous leukemia [PDF]

, 1979
LB Vogler, WM Crist, PC Vinson, A Sarrif, MG Brattain, MS Coleman   +5 more
openalex   +1 more source

Hydroxyurea therapy in chronic myelogenous leukemia [PDF]

, 1972
B. J. Kennedy
openalex   +1 more source

Management of chronic myelogenous leukemia with COVID-19 and hepatitis B. [PDF]

Front Oncol, 2023
Yu T, Li W, Yu T.
europepmc   +1 more source